https://www.zonebourse.com/cours/action/EMERGENT-BIOSOLUTIONS-INC-36547/actualite/Emergent-BioSolutions-lance-une-etude-de-phase-1-evaluant-un-traitement-intranasal-potentiel-pour-39748550/?utm_source=telegram&utm_medium=social&utm_campaign=share